Hepatocellular Carcinoma in Liver Cirrhosis: Surgical Resection versus Transarterial Chemoembolization—A Meta-Analysis
We compare the value of TACE to liver resection for patients with BCLC stage A and B HCC. For patients with HCC in cirrhosis LT is the treatment of choice. TACE represents the current standard for unresectable BCLC stage B patients not eligible for LT. Recently liver resection for HCC and significan...
Saved in:
Main Authors: | Teodor Kapitanov, Ulf P. Neumann, Maximilian Schmeding |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2015/696120 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01) -
A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
by: Adriana Toro, et al.
Published: (2015-01-01) -
Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: A. Rebonato, et al.
Published: (2017-01-01) -
Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2019-12-01) -
Clinical Outcomes of Drug-Eluting Bead Transarterial Chemoembolization Loaded with Raltitrexed for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
by: Yonghua Bi, et al.
Published: (2022-01-01)